Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
Title:
Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
Author:
Ladang, Aurélie Beaudart, Charlotte Reginster, Jean-Yves Al-Daghri, Nasser Bruyère, Olivier Burlet, Nansa Cesari, Matteo Cherubini, Antonio da Silva, Mario Coelho Cooper, Cyrus Cruz-Jentoft, Alfonso J. Landi, Francesco Laslop, Andrea Maggi, Stefania Mobasheri, Ali Ormarsdottir, Sif Radermecker, Régis Visser, Marjolein Yerro, Maria Concepcion Prieto Rizzoli, René Cavalier, Etienne